Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: A new use for an old friend

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2423-2427

  Peters, Anne L ^a,b   Davidson, Mayer B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KETONES; MALE; MIDDLE AGED; POLYURIA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; URINATION DISORDERS; WEIGHT LOSS;

EID: 0029955232     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2423     Document Type: Article

References (10)

1. Davidson MB. 1992 Successful treatment of markedly symptomatic patients with type 2 diabetes using high doses of sulfonylurea agents. West J Med. 157:199-200.
2. Glantz SA. 1987 Primer of biostatistics, 2nd ed. New York: McGraw-Hill; 91-86:267-271.
3. Genuth S. 1990 Insulin use in NIDDM. Diabetes Care. 13:1240-1264.
4. American Diabetes Association. 1988 Physician's guide to non-insulin-dependent (type II) diabetes. Diagnosis and treatment. Alexandria: American Diabetes Association.
5. ADA Consensus Panel. 1995 The pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care. 18:1510-1518.
6. Cohen M, Crosbie C, Cusworth L, et al. 1984 Insulin-not always a life sentence: withdrawal of insulin therapy in non-insulin dependent diabetes. Diabetes Res. 1:31-34.
7. Bailey CJ. 1992 Biguanides and NIDDM. Diabetes Care. 15:755-772.
8. Groop LC, Luzi L, DeFronzo RA, Melander A. 1989 Hyperglycaemia and absorption of sulphonylurea drugs. Lancet. 2:129-130.
9. Peters AL, Davidson MB. 1994 BIDS therapy for treatment of NIDDM: effectiveness, and predictors (if any) of success. Diabetes Spectrum. 7:152-158.
10. Klein R, Klein BE, Moss SE, et al. 1988 Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 260:2864-2871.